ASX - By Stock
|
IMR |
Re:
Ann: Ethics Committee Approval by ICPS for VISABL-AFL Trial
|
|
valueprospector
|
1 |
454 |
3 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
1
|
454
|
3
|
|
ASX - By Stock
|
CYC |
Re:
Ann: Cyclopharm Trading and USA Launch Update
|
|
valueprospector
|
31 |
8.5K |
2 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
31
|
8.5K
|
2
|
|
ASX - By Stock
|
CYC |
Re:
Ann: Cyclopharm Trading and USA Launch Update
|
|
valueprospector
|
31 |
8.5K |
3 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
31
|
8.5K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
valueprospector
|
423 |
190K |
6 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
423
|
190K
|
6
|
|
ASX - By Stock
|
TYR |
Re:
Ann: Tyro Payments H1 FY24 Investor Presentation
|
|
valueprospector
|
75 |
26K |
0 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
75
|
26K
|
0
|
|
ASX - By Stock
|
CYC |
Re:
Ann: Cyclopharm Signs First USA Contract for Technegas
|
|
valueprospector
|
39 |
13K |
5 |
06/12/23 |
06/12/23 |
ASX - By Stock
|
39
|
13K
|
5
|
|
ASX - By Stock
|
CYC |
Re:
Ann: Cyclopharm Signs First USA Contract for Technegas
|
|
valueprospector
|
39 |
13K |
4 |
06/12/23 |
06/12/23 |
ASX - By Stock
|
39
|
13K
|
4
|
|
ASX - By Stock
|
CYC |
Re:
Ann: Cyclopharm Signs First USA Contract for Technegas
|
|
valueprospector
|
39 |
13K |
2 |
06/12/23 |
06/12/23 |
ASX - By Stock
|
39
|
13K
|
2
|
|
ASX - By Stock
|
CYC |
Re:
Ann: Cyclopharm Signs First USA Contract for Technegas
|
|
valueprospector
|
39 |
13K |
2 |
05/12/23 |
05/12/23 |
ASX - By Stock
|
39
|
13K
|
2
|
|
ASX - By Stock
|
ORG |
Re:
A Mystery
|
|
valueprospector
|
35 |
15K |
2 |
05/12/23 |
05/12/23 |
ASX - By Stock
|
35
|
15K
|
2
|
|
ASX - By Stock
|
HCL |
Re:
Ann: XTEK AGM Group CEO Address to Shareholders and Update
|
|
valueprospector
|
23 |
6.9K |
0 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
23
|
6.9K
|
0
|
|
ASX - By Stock
|
IMR |
Bayer shares plunge after blood-thinning drug trial halted
|
|
valueprospector
|
3 |
1.4K |
1 |
21/11/23 |
21/11/23 |
ASX - By Stock
|
3
|
1.4K
|
1
|
|
ASX - By Stock
|
IMR |
Re:
Ann: Imricor Q3 FY23 Quarterley Activities Report and Appendix 4C
|
|
valueprospector
|
1 |
663 |
2 |
13/11/23 |
13/11/23 |
ASX - By Stock
|
1
|
663
|
2
|
|
ASX - By Stock
|
CVV |
Re:
Caravel Copper Project - Bankable Feasibility Study
|
|
valueprospector
|
213 |
85K |
1 |
13/11/23 |
13/11/23 |
ASX - By Stock
|
213
|
85K
|
1
|
|
ASX - By Stock
|
CYC |
Re:
Ann: FDA Technegas Approval Webinar
|
|
valueprospector
|
64 |
16K |
3 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
64
|
16K
|
3
|
|
ASX - By Stock
|
CYC |
Re:
Ann: FDA Technegas Approval Webinar
|
|
valueprospector
|
64 |
16K |
0 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
64
|
16K
|
0
|
|
ASX - By Stock
|
IMR Medicine |
Re:
Anyone still following this one? This sounds promising….
|
|
valueprospector
|
5 |
2.6K |
1 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
5
|
2.6K
|
1
|
|
ASX - By Stock
|
CYC |
Re:
Ann: FDA Technegas Approval Webinar
|
|
valueprospector
|
64 |
16K |
3 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
64
|
16K
|
3
|
|
ASX - By Stock
|
CYC |
Re:
Ann: FDA Technegas Approval Webinar
|
|
valueprospector
|
64 |
16K |
0 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
64
|
16K
|
0
|
|
ASX - By Stock
|
CYC |
Re:
Ann: FDA Technegas Approval Webinar
|
|
valueprospector
|
64 |
16K |
0 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
64
|
16K
|
0
|
|
ASX - By Stock
|
CYC |
Re:
Ann: FDA Technegas Approval Webinar
|
|
valueprospector
|
64 |
16K |
0 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
64
|
16K
|
0
|
|
ASX - By Stock
|
CYC |
Re:
Ann: FDA Technegas Approval Webinar
|
|
valueprospector
|
64 |
16K |
0 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
64
|
16K
|
0
|
|
ASX - By Stock
|
CYC |
Re:
Ann: FDA Technegas Approval Webinar
|
|
valueprospector
|
64 |
16K |
3 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
64
|
16K
|
3
|
|
ASX - By Stock
|
CVB |
Re:
Ann: Quarterly Activities Webinar Presentation - Sep 2023 Qtr
|
|
valueprospector
|
7 |
4.4K |
2 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
7
|
4.4K
|
2
|
|
ASX - By Stock
|
CYC |
Re:
Ann: FDA Technegas Approval Webinar
|
|
valueprospector
|
64 |
16K |
11 |
10/10/23 |
10/10/23 |
ASX - By Stock
|
64
|
16K
|
11
|
|
ASX - By Stock
|
CYC |
Re:
Ann: FDA Technegas Approval Webinar
|
|
valueprospector
|
64 |
16K |
10 |
09/10/23 |
09/10/23 |
ASX - By Stock
|
64
|
16K
|
10
|
|
ASX - By Stock
|
MFG |
Re:
Ann: Funds Under Management - September 2023
|
|
valueprospector
|
135 |
65K |
0 |
09/10/23 |
09/10/23 |
ASX - By Stock
|
135
|
65K
|
0
|
|
ASX - By Stock
|
MFG |
Re:
Ann: Funds Under Management - September 2023
|
|
valueprospector
|
135 |
65K |
1 |
09/10/23 |
09/10/23 |
ASX - By Stock
|
135
|
65K
|
1
|
|
ASX - By Stock
|
CYC |
Re:
Confidence Waning
|
|
valueprospector
|
14 |
4.0K |
1 |
06/10/23 |
06/10/23 |
ASX - By Stock
|
14
|
4.0K
|
1
|
|
ASX - By Stock
|
MFG |
Re:
Ann: Funds Under Management - September 2023
|
|
valueprospector
|
135 |
65K |
10 |
06/10/23 |
06/10/23 |
ASX - By Stock
|
135
|
65K
|
10
|
|
ASX - By Stock
|
MFG |
Re:
Ann: Funds Under Management - September 2023
|
|
valueprospector
|
135 |
65K |
10 |
06/10/23 |
06/10/23 |
ASX - By Stock
|
135
|
65K
|
10
|
|
ASX - By Stock
|
CYC |
Re:
Ann: FDA Technegas Approval Webinar
|
|
valueprospector
|
64 |
16K |
4 |
05/10/23 |
05/10/23 |
ASX - By Stock
|
64
|
16K
|
4
|
|
ASX - By Stock
|
CYC |
Re:
Ann: FDA Technegas Approval Webinar
|
|
valueprospector
|
64 |
16K |
2 |
05/10/23 |
05/10/23 |
ASX - By Stock
|
64
|
16K
|
2
|
|
ASX - By Stock
|
CYC |
Re:
Ann: FDA Technegas Approval Webinar
|
|
valueprospector
|
64 |
16K |
2 |
05/10/23 |
05/10/23 |
ASX - By Stock
|
64
|
16K
|
2
|
|
ASX - By Stock
|
CYC |
Re:
Ann: Cyclopharm Receives USFDA Approval for Technegas
|
|
valueprospector
|
41 |
10K |
3 |
02/10/23 |
02/10/23 |
ASX - By Stock
|
41
|
10K
|
3
|
|
ASX - By Stock
|
CYC |
Re:
Ann: Cyclopharm Receives USFDA Approval for Technegas
|
|
valueprospector
|
41 |
10K |
7 |
02/10/23 |
02/10/23 |
ASX - By Stock
|
41
|
10K
|
7
|
|
ASX - By Stock
|
CYC |
Re:
Countdown
|
|
valueprospector
|
65 |
18K |
1 |
30/09/23 |
30/09/23 |
ASX - By Stock
|
65
|
18K
|
1
|
|
ASX - By Stock
|
CYC |
Re:
Countdown
|
|
valueprospector
|
65 |
18K |
0 |
30/09/23 |
30/09/23 |
ASX - By Stock
|
65
|
18K
|
0
|
|
ASX - By Stock
|
CYC |
Re:
Bit of a Shitty Day
|
|
valueprospector
|
12 |
2.9K |
3 |
27/09/23 |
27/09/23 |
ASX - By Stock
|
12
|
2.9K
|
3
|
|
ASX - By Stock
|
CYC |
Re:
Ann: Cyclopharm Investor Update
|
|
valueprospector
|
2 |
1.1K |
6 |
26/09/23 |
26/09/23 |
ASX - By Stock
|
2
|
1.1K
|
6
|
|
ASX - By Stock
|
CYC |
Re:
Ann: Application for quotation of securities - CYC
|
|
valueprospector
|
13 |
4.5K |
0 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
13
|
4.5K
|
0
|
|
ASX - By Stock
|
CYC |
Re:
Ann: Application for quotation of securities - CYC
|
|
valueprospector
|
13 |
4.5K |
0 |
20/09/23 |
20/09/23 |
ASX - By Stock
|
13
|
4.5K
|
0
|
|
ASX - By Stock
|
CYC |
Re:
Ann: Application for quotation of securities - CYC
|
|
valueprospector
|
13 |
4.5K |
1 |
20/09/23 |
20/09/23 |
ASX - By Stock
|
13
|
4.5K
|
1
|
|
ASX - By Stock
|
CYC |
Re:
Ann: Application for quotation of securities - CYC
|
|
valueprospector
|
13 |
4.5K |
2 |
13/09/23 |
13/09/23 |
ASX - By Stock
|
13
|
4.5K
|
2
|
|
ASX - By Stock
|
CYC |
Re:
Countdown
|
|
valueprospector
|
65 |
18K |
2 |
28/08/23 |
28/08/23 |
ASX - By Stock
|
65
|
18K
|
2
|
|
ASX - By Stock
|
CYC |
Re:
Ann: Litigation Update and Receipt of Settlement Payment
|
|
valueprospector
|
2 |
1.0K |
5 |
25/08/23 |
25/08/23 |
ASX - By Stock
|
2
|
1.0K
|
5
|
|
ASX - By Stock
|
CYC |
Re:
Ann: Half Year Accounts
|
|
valueprospector
|
2 |
968 |
7 |
22/08/23 |
22/08/23 |
ASX - By Stock
|
2
|
968
|
7
|
|
ASX - By Stock
|
CYC |
Re:
Half Year Announcement
|
|
valueprospector
|
3 |
811 |
4 |
22/08/23 |
22/08/23 |
ASX - By Stock
|
3
|
811
|
4
|
|
ASX - By Stock
|
MFG |
Re:
Ann: Final Results for the year ended 30 June 2023
|
|
valueprospector
|
87 |
36K |
4 |
18/08/23 |
18/08/23 |
ASX - By Stock
|
87
|
36K
|
4
|
|
ASX - By Stock
|
MFG |
Re:
Shorters are crying
|
|
valueprospector
|
121 |
71K |
10 |
18/08/23 |
18/08/23 |
ASX - By Stock
|
121
|
71K
|
10
|
|